Latest Johnson & Johnson Vision contact lens innovation to launch across the US, Canada and multiple European countries in autumn 2022


71% of eye care professionals say patients are reporting issues with eye comfort due to screen time. (Credit: Martin Slavoljubovski from Pixabay)

Johnson & Johnson Vision, a global leader in eye health and part of Johnson & Johnson MedTech, today announced it has received U.S. Food & Drug Administration (FDA) clearance, Health Canada approval and completed CE Mark activities for its latest contact lens innovation, ACUVUE OASYS MAX 1-Day and ACUVUE OASYS MAX 1-Day MULTIFOCAL. The announcement comes during the 125th Annual AOA Congress and 54th Annual AOSA Conference: Optometry’s Meeting 2022 in Chicago (June 15-18).

The new contact lenses were developed to provide all-day comfort and visual clarity, amidst feedback from eye care professionals and patients that today’s modern lifestyles, long hours and increased use of digital devices are taking a toll on eye comfort. A recent survey found the majority (71%) of eye care professionals are seeing patients who are experiencing eye discomfort related to increased screen-time,1 with young contact lens wearers spending an average of 9 hours per day in front of a screen, causing them to blink less and experience more dryness and eye fatigue.

“Our lives have evolved significantly over the past few years creating increased demands on our eyes,” said Peter Menziuso, Company Group Chairman, Johnson & Johnson Vision. As pioneers in eye health, we’re leading with high science and deep clinical expertise to innovate for those moments that matter. ACUVUE OASYS MAX 1-Day is the latest in our long heritage of leading-edge innovation and we look forward to bringing this solution for patients experiencing ever-demanding lifestyles and environments.”

Available in spherical and multifocal, ACUVUE OASYS MAX 1-Day contact lenses are designed to address multiple vision correction needs. They will be a premium range of daily disposable contact lenses designed for proven performance.

The new lenses are anticipated to be made available in the US, Canada and multiple European countries in the autumn.

Source: Company Press Release